0001209191-17-042325.txt : 20170629
0001209191-17-042325.hdr.sgml : 20170629
20170629164340
ACCESSION NUMBER: 0001209191-17-042325
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170627
FILED AS OF DATE: 20170629
DATE AS OF CHANGE: 20170629
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO THERAPEUTICS, INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
FORMER COMPANY:
FORMER CONFORMED NAME: SANGAMO BIOSCIENCES INC
DATE OF NAME CHANGE: 20000208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JEFFS ROGER
CENTRAL INDEX KEY: 0001231615
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 17938838
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-27
0
0001001233
SANGAMO THERAPEUTICS, INC
SGMO
0001231615
JEFFS ROGER
C/O SANGAMO THERAPEUTICS, INC.
POINT RICHMOND TECH CTR, 501 CANAL BLVD.
RICHMOND
CA
94804
1
0
0
0
Stock Option (Right to Buy)
8.70
2017-06-27
4
A
0
30000
0.00
A
2027-06-26
Common Stock
30000
30000
D
Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon the cessation of the Reporting Person's service on the Board of Directors of the Issuer. The shares subject to each option vest in monthly installments upon completion of each month of Board service over a three year period.
/s/ Kathy Yi, Attorney-in-Fact
2017-06-29